Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7261 AL 7275

CTAD taskforce: genetic therapies in Alzheimer's disease

Jakabek D, Isaacs AM, De Strooper B, Tuszynski M, Lane R, Uspenskaya O, McDade E, Rafii MS, Mummery CJ.

J Prev Alzheimers Dis. 2025 Sep;12(8):100269. doi: 10.1016/j.tjpad.2025.100269. Epub 2025 Jul 9.

Clinical Role of Brain PET in Alzheimer Disease in the Era of Disease-Modifying Therapies

Franceschi AM, Keir G, Benzinger TLS, Cogswell PM, Ali FZ, Petrella JR, Prescott JW, Whitlow CT, Zaharchuk G, Allen JW; American Society of Functional Neuroradiology (ASFNR).

AJNR Am J Neuroradiol. 2025 Aug 1;46(8):1521-1527. doi: 10.3174/ajnr.A8738.

Recent Advances in Antibody Therapy for Alzheimer's Disease: Focus on Bispecific Antibodies

Yang HM.

Int J Mol Sci. 2025 Jun 28;26(13):6271. doi: 10.3390/ijms26136271.

Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy

Almohmadi NH, Al-Kuraishy HM, Albuhadily AK, Al-Gareeb AI, Abdelaziz AM, Alexiou A, Papadakis M, El-Saber Batiha G.

J Pharmacol Exp Ther. 2025 Aug;392(8):103639. doi: 10.1016/j.jpet.2025.103639. Epub 2025 Jun 20.

Deciphering Molecular and Signaling Pathways of Extracellular Vesicles-Based Therapeutics for Alzheimer's Disease

Dhapola R, Kumari S, Sharma P, Paidlewar M, Medhi B, Vellingiri B, HariKrishnaReddy D.

Mol Neurobiol. 2025 Dec;62(12):15430-15449. doi: 10.1007/s12035-025-05216-6. Epub 2025 Jul 18.

Eriocitrin and its derivatives against Alzheimer's disease: Cumulative accounts of in vitro and in vivo studies

Kritika, Sanjay, Lee HJ.

Biomed Pharmacother. 2025 Sep;190:118362. doi: 10.1016/j.biopha.2025.118362. Epub 2025 Jul 21.

A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease

Alshehri GH, Al-Kuraishy HM, Al-Gareeb AI, Fawzy MN, Waheed HJ, Papadakis M, Alexiou A, El-Saber Batiha G.

Eur J Pharmacol. 2025 Sep 15;1003:177979. doi: 10.1016/j.ejphar.2025.177979. Epub 2025 Jul 22.

The role of peripheral innate immune cells in Alzheimer's disease progression

Cao Y, Tang K, Ma P, Zhang R, Yang Y, Li T, Zhang Y, Peng X.

Front Immunol. 2025 Jul 16;16:1616939. doi: 10.3389/fimmu.2025.1616939. eCollection 2025.

Alzheimer's disease: unraveling role of xanthone derivatives and nanocarriers

Suhaili INA, Yow HY, Mah SH, Zaman Huri H, Tan SLJ.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Jan;399(1):1-17. doi: 10.1007/s00210-025-04446-8. Epub 2025 Aug 1.

Phytocompounds as modulators of HSF1 in neurodegenerative disease: Special emphasis on Alzheimer's disease

Nelson VK, Begum MY, Dera AA, Ali SP, Suryadevara PR.

Eur J Pharmacol. 2025 Oct 15;1005:178034. doi: 10.1016/j.ejphar.2025.178034. Epub 2025 Aug 5.

Hippocampal neural stem cells in Alzheimer's disease: bridging neurogenesis, extracellular vesicles, and multimodal therapeutic paradigms

Li R, Xiong W, Sun C.

Int J Neurosci. 2026 Mar;136(3):380-400. doi: 10.1080/00207454.2025.2540989. Epub 2025 Aug 8.

Understanding the role of microglia in Alzheimer's disease: insights into mechanisms, acupuncture, and potential therapeutic targets

Jinglei J, Tao YU, Yulin Q, Meng W.

J Tradit Chin Med. 2025 Aug;45(4):922-936. doi: 10.19852/j.cnki.jtcm.20250327.002.

Rationale and emerging evidence for microglial replacement in Alzheimer's disease

Bang JY, Yoo Y.

Mol Cells. 2025 Oct;48(10):100265. doi: 10.1016/j.mocell.2025.100265. Epub 2025 Aug 14.

PANoptosis: Potential Therapeutic Prospects in Alzheimer's Disease

Guo Z, Wan Y.

Eur J Neurosci. 2025 Aug;62(4):e70231. doi: 10.1111/ejn.70231.

The emerging role of disulfidptosis in Alzheimer's disease

Zhou Q, Zheng N, Chen Z, Xie L, Yang X, Sun Q, Lin J, Li B, Li L.

Eur J Pharmacol. 2025 Oct 15;1005:178085. doi: 10.1016/j.ejphar.2025.178085. Epub 2025 Aug 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias